Page 1 of 1

Antisense Therapeutics

Posted: Mon Oct 03, 2005 12:48 pm
by bromley
Antisense Therapeutics were trialling an oral drug which targeted the same protein as Tysabri. The company stopped the trial following the Tysabri fiasco. The company has applied to restart the trial (may need to add to Dignan's list of approval given).


http://www.antisense.com.au/dl/415.pdf